NEOADJUVANT LENVATINIB IN ADVANCED UNRESECTABLE MEDULLARY THYROID CARCINOMA: A CASE REPORT

OBJECTIVE: Medullary thyroid carcinoma, a rare form of thyroid cancer, is typically managed with surgical excision. However, in patients with locally-invasive tumors, an aggressive surgical attempt may result in unnecessary morbidity. Neoadjuvant tyrosine kinase inhibition has been utilized to downs...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:AACE Clin Case Rep
Glavni autori: Golingan, Hubert, Hunis, Brian, Golding, Allan C., Bimston, David N., Harrell, R. Mack
Format: Artigo
Jezik:Inglês
Izdano: American Association of Clinical Endocrinologists 2019
Teme:
Case Reports
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7282158/
https://ncbi.nlm.nih.gov/pubmed/32524015
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4158/ACCR-2019-0365
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items